Freya Biosciences ApS

CVR 41257547 · Private limited company (ApS) · Active · Low risk

Freya Biosciences ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 6 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 72.0m and a net result of DKK -92.7m.

Bankruptcy risk for Freya Biosciences ApS

0.5%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 60% of active Danish companies

Lowest riskHighest risk

Increases the risk

Share of late annual reports75%+ · bankruptcy rate 29.8%3.4×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Registered owners4+ · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
41257547
Status
Active
Company type
Private limited company (ApS)
Founded
(6 years)
Address
Fruebjergvej 3
2100 København Ø
Municipality
København
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 1.2m
Auditor
EY Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late5 of 6
Missing annual reportNo
Negative equityNo
Equity ratio87.4%
Current ratio794%
Moves (last 2 years)0
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address611
Going-concern uncertaintyYes

Financials and key figures

Financial year202520242023
Gross profitDKK -14.1mDKK -6.7mDKK -5.4m
Net profitDKK -92.7mDKK -85.4mDKK -81.1m
EquityDKK 72.0mDKK 130.1mDKK 75.0m
Total assetsDKK 82.4mDKK 141.4mDKK 81.8m
CashDKK 73.5mDKK 133.2m–
Short-term debtDKK 10.4mDKK 11.4m–
Avg. employees2314–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · (venstre underskriver).

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025183
1 Jan 2024 – 31 Dec 2024188 Late
1 Jan 2023 – 31 Dec 2023177
1 Jan 2022 – 31 Dec 2022184 Late
1 Jan 2021 – 31 Dec 2021187 Late
23 Mar 2020 – 31 Dec 2020194 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEORandi Rich
BoardPeter Finsel BisgaardCurrent
BoardHenrijette Elsebeth RichterCurrent
BoardColleen Denise AcostaCurrent
BoardMark SmithCurrent
BoardNicholas HaftCurrent
BoardClaudia Maria ColciagoCurrent
BoardDavid Lawrence SternCurrent
BoardThomas Gundelund Rasmussen
BoardJohannes Epeüs Theodoor van Hylckama Vlieg
Owner (5%)OMX Opportunity Fund I, LLCCurrent
Owner (10%)Danmarks Eksport- og InvesteringsfondCurrent
Owner (10%)OMX Ventures Fund I, LLCCurrent
Owner (10%)Sofinnova Capital IXCurrent
Owner (10%)Bill & Melinda Gates FoundationCurrent
Owner (15%)Sofinnova Capital XCurrent
Owner (33%)Peter Finsel Bisgaard
Owner (33%)Origem Holding ApS
Owner (33%)MBFH Consulting SAS
Owner (20%)Peter Finsel Bisgaard
Owner (20%)Origem Holding ApS
Owner (5%)ABT Consult ApS
Owner (20%)Curanthia Holdings ApS
Owner (5%)R. Rich Holding ApS
Owner (20%)MBFH Consulting SAS
Owner (10%)Peter Finsel Bisgaard
Owner (10%)Origem Holding ApS
Owner (10%)Curanthia Holdings ApS
Owner (10%)MBFH Consulting SAS
Owner (10%)OMX Ventures Fund I, LLC
Owner (10%)Sofinnova Capital IX
Owner (20%)OMX Ventures Fund I, LLC
Owner (20%)Sofinnova Capital IX
Owner (5%)Peter Finsel Bisgaard
Owner (5%)VÆKSTFONDEN
Owner (5%)Origem Holding ApS
Owner (5%)Curanthia Holdings ApS
Owner (5%)MBFH Consulting SAS
Owner (15%)OMX Ventures Fund I, LLC
Owner (15%)Sofinnova Capital IX
Owner (15%)Sofinnova Capital X
Owner (5%)Danmarks Eksport- og Investeringsfond
Owner (20%)Sofinnova Capital X
Owner (5%)Bill & Melinda Gates Foundation
AuditorEY Godkendt RevisionspartnerselskabCurrent
FounderPeter Finsel BisgaardCurrent
FounderOrigem Holding ApSCurrent
FounderMBFH Consulting SASCurrent

The CEOs' other companies

Randi Rich – 1 other companies

Address history (1 moves)

Fruebjergvej 3, 2100 København Ø
c/o Gorrissen Federspiel, Axeltorv 2, 1609 København V

Other companies at the same address

Similar companies in København

Questions and answers about Freya Biosciences ApS

Has Freya Biosciences ApS gone bankrupt?

No, Freya Biosciences ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Freya Biosciences ApS?

Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the auditor of Freya Biosciences ApS?

Freya Biosciences ApS most recently used EY Godkendt Revisionspartnerselskab.

When was Freya Biosciences ApS founded?

Freya Biosciences ApS was founded on 23 March 2020.

What is the equity of Freya Biosciences ApS?

Equity was DKK 72.0m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.